Literature DB >> 10848773

Fexofenadine-induced QT prolongation: a myth or fact?

S Dhar, P K Hazra, S Malakar, G Mistri.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10848773     DOI： 10.1046/j.1365-2133.2000.03576.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  5 in total

1.  Non-antiarrhythmic drugs prolonging the QT interval: considerable use in seven countries.

Authors:  Fabrizio De Ponti; Elisabetta Poluzzi; Alberto Vaccheri; Ulf Bergman; Lars Bjerrum; John Ferguson; Kerry J Frenz; Peter McManus; Ingrid Schubert; Gisbert Selke; Georgia Terzis-Vaslamatzis; Nicola Montanaro
Journal:  Br J Clin Pharmacol       Date:  2002-08       Impact factor: 4.335

2.  Blinded validation of the isolated arterially perfused rabbit ventricular wedge in preclinical assessment of drug-induced proarrhythmias.

Authors:  Tengxian Liu; Barry S Brown; Ying Wu; Charles Antzelevitch; Peter R Kowey; Gan-Xin Yan
Journal:  Heart Rhythm       Date:  2006-04-22       Impact factor: 6.343

3.  The antihistamine fexofenadine does not affect I(Kr) currents in a case report of drug-induced cardiac arrhythmia.

Authors:  Constanze R Scherer; Christian Lerche; Niels Decher; Adrienne T Dennis; Patrick Maier; Eckhard Ficker; Andreas E Busch; Bernd Wollnik; Klaus Steinmeyer
Journal:  Br J Pharmacol       Date:  2002-11       Impact factor: 8.739

4.  Fexofenadine hydrochloride in the treatment of allergic disease: a review.

Authors:  David Axelrod; Leonard Bielory
Journal:  J Asthma Allergy       Date:  2008-09-19

5.  Pro-arrhythmic potential of oral antihistamines (H1): combining adverse event reports with drug utilization data across Europe.

Authors:  Elisabetta Poluzzi; Emanuel Raschi; Brian Godman; Ariola Koci; Ugo Moretti; Marija Kalaba; Bjorn Wettermark; Miriam Sturkenboom; Fabrizio De Ponti
Journal:  PLoS One       Date:  2015-03-18       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.